Discuss the globalization of R&D and its impact on India's development. Provide an illustration from at least one sector such as Information Technology or Health.
Explain what R&D globalisation means and why it has come to India, then weigh its benefits and limits for India's development with at least one sectoral illustration.
Common trap: Many answers only list MNC labs. A good answer explains the drivers, gives named examples from IT and health, and then critically assesses spillovers versus enclave effects and IP ownership.
SyllabusOld-pattern GS Paper II (2006–12): Developments in the field of Science and Technology — their impact on India's development
Model answer
25 marks · 250-word limitGlobalisation of R&D means that firms locate research, design and development across countries instead of only at headquarters. Since the 1990s India has become one of the largest hosts of foreign R&D centres, drawn by its scientific talent, cost advantage and large market, with mixed but largely positive effects on development.
- Talent pool and lower costs
- MNC R&D centres set up in India
- Skills, patents and products created
- Spillovers to Indian firms and start-ups
- Growth, exports and better products
Drivers of R&D globalisation
- Talent and cost: India produces a very large number of engineers and science graduates every year, at a fraction of Western costs.
- Policy change: Liberalisation after 1991, automatic route FDI and the Patents (Amendment) Act, 2005 introducing product patents made India TRIPS-compliant and safer for research.
- Market proximity: Firms want to design for emerging-market consumers close to them.
Illustration: Information Technology
- Early movers: Texas Instruments opened a Bangalore design centre in 1985; GE's John F. Welch Technology Centre, Microsoft Research India, Intel and IBM followed.
- Impact: Engineering and R&D services became a major export line, chip design and embedded software capability grew, and returning engineers seeded start-ups.
- Frugal innovation: GE Healthcare's low-cost portable ECG machine designed in India is a well-known case of products developed here for global markets.
Illustration: Health and pharmaceuticals
- Contract research: Product patents and a skilled workforce made India a centre for clinical trials, contract research and drug discovery partnerships with global firms.
- Concerns: Unregulated clinical trials raised ethical questions in 2011–12, and patented drugs threaten affordability; Section 3(d) of the Patents Act guards against evergreening.
Limits for India's development
- Enclave effect: Most patents filed by foreign labs in India are owned by the parent company, so intellectual property and royalties flow abroad.
- Weak domestic base: India's gross expenditure on R&D stays below one per cent of GDP and industry–academia links are thin, limiting absorption.
- Talent pull: High MNC salaries can draw scientists away from public laboratories and universities.
Globalised R&D has made India a knowledge destination and raised skills, but development gains depend on spillovers. Raising public and private R&D spending, protecting IP while safeguarding access to medicines, and linking MNC centres with Indian universities and firms will turn hosting research into owning innovation.
Read more — sources
- OfficialDepartment of Science and Technology, Science, Technology and Innovation Policy 2013 (draft discussed in 2012)
- ReportUNCTAD, World Investment Report 2005: Transnational Corporations and the Internationalization of R&D
- ReportNASSCOM Strategic Review (annual) — Engineering and R&D services
- OfficialThe Patents (Amendment) Act, 2005
More from GS Paper II (old) 2012
Model answer by the EdiShorts editorial team. It is one well-argued treatment of the question, written to the official word limit — not an official UPSC answer key.